164 related articles for article (PubMed ID: 27671309)
21. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres.
Seo EJ; Wiench B; Hamm R; Paulsen M; Zu Y; Fu Y; Efferth T
Phytomedicine; 2015 Apr; 22(4):438-43. PubMed ID: 25925965
[TBL] [Abstract][Full Text] [Related]
23. Effects of melatonin on apoptosis and cell differentiation in MCF-7 derived cancer stem cells.
Koçak N; Dönmez H; Yildirim İH
Cell Mol Biol (Noisy-le-grand); 2018 Sep; 64(12):56-61. PubMed ID: 30301504
[TBL] [Abstract][Full Text] [Related]
24. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line.
Maroufi NF; Rashidi M; Vahedian V; Jahanbazi R; Mostafaei S; Akbarzadeh M; Kazemzadeh H; Nejabati HR; Isazadeh A; Rashidi MR; Nouri M
Breast Cancer; 2022 Mar; 29(2):260-273. PubMed ID: 34725795
[TBL] [Abstract][Full Text] [Related]
25. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
26. Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics.
Chekhun VF; Borikun TV; Lukianova NY
Exp Oncol; 2016 Mar; 38(1):26-30. PubMed ID: 27031715
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines.
Gelaleti GB; Borin TF; Maschio-Signorini LB; Moschetta MG; Jardim-Perassi BV; Calvinho GB; Facchini MC; Viloria-Petit AM; de Campos Zuccari DAP
Life Sci; 2017 Aug; 183():98-109. PubMed ID: 28624391
[TBL] [Abstract][Full Text] [Related]
28. The impact of different extracellular matrices on melatonin effect in proliferation and stemness properties of ovarian cancer cells.
Akbarzadeh M; Rahbarghazi R; Nabat E; Movassaghpour AA; Shanehbandi D; Faramarzian Azimi Maragheh B; Matluobi D; Barazvan B; Kazemi M; Samadi N; Nouri M
Biomed Pharmacother; 2017 Mar; 87():288-295. PubMed ID: 28063410
[TBL] [Abstract][Full Text] [Related]
29. A High-Throughput Image Cytometry Method for the Formation, Morphometric, and Viability Analysis of Drug-Treated Mammospheres.
Kessel SL; Chan LL
SLAS Discov; 2020 Aug; 25(7):723-733. PubMed ID: 32396489
[TBL] [Abstract][Full Text] [Related]
30. Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation.
Vuong T; Mallet JF; Ouzounova M; Rahbar S; Hernandez-Vargas H; Herceg Z; Matar C
J Transl Med; 2016 Jan; 14():13. PubMed ID: 26762586
[TBL] [Abstract][Full Text] [Related]
31. 3-O-methylfunicone, from Penicillium pinophilum, is a selective inhibitor of breast cancer stem cells.
Buommino E; Tirino V; De Filippis A; Silvestri F; Nicoletti R; Ciavatta ML; Pirozzi G; Tufano MA
Cell Prolif; 2011 Oct; 44(5):401-9. PubMed ID: 21951283
[TBL] [Abstract][Full Text] [Related]
32. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
33. Melatonin Differentially Modulates NF-кB Expression in Breast and Liver Cancer Cells.
Colombo J; Jardim-Perassi BV; Ferreira JPS; Braga CZ; Sonehara NM; Júnior RP; Moschetta MG; Girol AP; Zuccari DAPC
Anticancer Agents Med Chem; 2018; 18(12):1688-1694. PubMed ID: 29384062
[TBL] [Abstract][Full Text] [Related]
34. Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis.
Lee JH; Yun CW; Han YS; Kim S; Jeong D; Kwon HY; Kim H; Baek MJ; Lee SH
J Pineal Res; 2018 Nov; 65(4):e12519. PubMed ID: 30091203
[TBL] [Abstract][Full Text] [Related]
35. Novel anticancer activity of phloroglucinol against breast cancer stem-like cells.
Kim RK; Uddin N; Hyun JW; Kim C; Suh Y; Lee SJ
Toxicol Appl Pharmacol; 2015 Aug; 286(3):143-50. PubMed ID: 25843036
[TBL] [Abstract][Full Text] [Related]
36. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
37. Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27.
Lu KT; Wang BY; Chi WY; Chang-Chien J; Yang JJ; Lee HT; Tzeng YM; Chang WW
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27136586
[TBL] [Abstract][Full Text] [Related]
38. Genistein-induced differentiation of breast cancer stem/progenitor cells through a paracrine mechanism.
Liu Y; Zou T; Wang S; Chen H; Su D; Fu X; Zhang Q; Kang X
Int J Oncol; 2016 Mar; 48(3):1063-72. PubMed ID: 26794366
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of chemotherapy and P2Et extract combination in ex-vivo derived tumor mammospheres from breast cancer patients.
Urueña C; Sandoval TA; Lasso P; Tawil M; Barreto A; Torregrosa L; Fiorentino S
Sci Rep; 2020 Nov; 10(1):19639. PubMed ID: 33184339
[TBL] [Abstract][Full Text] [Related]
40. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
